Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice: final results of the PERLE study.
Leuk Lymphoma
; 60(6): 1563-1567, 2019 06.
Article
in En
| MEDLINE
| ID: mdl-30624147
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
/
Rituximab
/
Antineoplastic Agents, Immunological
Type of study:
Clinical_trials
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2019
Document type:
Article
Affiliation country:
Francia